Healthcare Services

Menopause Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Menopause Market Between 2026 And 2030?

The menopause market has experienced robust expansion in recent years. It is anticipated to grow from $18.78 billion in 2025 to $19.95 billion in 2026, registering a compound annual growth rate (CAGR) of 6.2%. Historically, the market’s advancement was propelled by an aging female population, increased life expectancy among women, widespread use of hormone replacement therapy, growing awareness of menopausal symptoms, and the expansion of women’s healthcare services.

The menopause market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $26.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This anticipated growth during the forecast period stems from factors such as increasing demand for safer long-term therapeutic options, the proliferation of digital health platforms dedicated to menopause, an elevated emphasis on preventive women’s health, broader availability of online pharmacies, and enhanced acceptance of alternative and lifestyle-oriented treatments. Key trends anticipated within the forecast timeframe encompass the expanding embrace of non-hormonal menopause interventions, heightened awareness leading to proactive menopause management, a growing inclination towards dietary supplements and natural remedies, the broadening of personalized menopause care initiatives, and an elevated need for solutions targeting specific symptoms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13190&type=smp

What Drivers Are Influencing The Menopause Market?

The menopause market is anticipated to experience growth driven by an increase in evolving lifestyles, which pertain to shifts in how individuals live and make decisions affecting their health and well-being. During this natural biological phase, adapting one’s lifestyle can aid in controlling menopausal symptoms and enhancing overall health. Menopause offers an opportunity to modify lifestyle choices in various ways, including adopting a nutritious diet, engaging in frequent exercise, ensuring sufficient sleep, refraining from smoking and excessive alcohol consumption, and participating in calming hobbies. For instance, in November 2023, the Global Wellness Institution, a US-based organization, released information stating that in 2022, the wellness economy constituted 5.6% of global economic output and is projected to grow to $8.5 trillion by 2027, demonstrating an average annual growth rate of 8.6%. Consequently, the increasing adoption of changing lifestyles is fueling the expansion of the menopause market.

Which Market Segments Are Examined In The Menopause Market Study?

The menopause market covered in this report is segmented –

1) By Treatment: Dietary Supplements, Over-The-Counter (OTC) Pharma Products

2) By Route Of Administration: Topical, Oral, Injectables

3) By Distribution Channel: Hospital, Retail, Online Pharmacies

4) By End User: Hospital, Diagnostic Centers, Specialty Clinics, Other End Users

Subsegments:

1) By Dietary Supplements: Herbal Supplements, Vitamins And Minerals, Phytoestrogens, Omega-3 Fatty Acids, Probiotics

2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT), Non-Hormonal OTC Products, Antidepressants For Mood Swings, Sleep Aids, Pain Relievers

Which Trends Are Shaping The Future Of The Menopause Market?

Major companies operating in the menopause market are focusing on developing innovative therapies, such as dual neurokinin 1/neurokinin 3 (NK1/NK3) receptor antagonists, to offer hormone-free alternatives for vasomotor symptoms (hot flashes and night sweats) and improve quality of life for menopausal women. Dual neurokinin 1/neurokinin 3 receptor antagonists refer to oral pharmaceuticals that simultaneously block both NK1 and NK3 receptors in the hypothalamus, thereby modulating the neuropeptide pathways responsible for thermoregulation and sweat responses and reducing the frequency and severity of hot flashes and associated sleep disturbances. For instance, in October 2025, Bayer AG, a Germany-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for Lynkuet (elinzanetant) 60 mg capsules, the world’s first dual-NK1/NK3 receptor antagonist approved for the treatment of moderate to severe hot flashes due to menopause. Lynkuet offers once-daily bedtime dosing, significant reductions in both frequency and severity of hot flashes as demonstrated in three Phase III trials (OASIS 1/2/3), and a non-hormonal mechanism of action that broadens treatment options for women contraindicated for hormone therapy.

Who Are The Primary Competitors In The Menopause Market?

Major companies operating in the menopause market are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A, Abbott Laboratories Ltd., GSK plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., Serenity Pharmaceuticals LLC

Read the full menopause market report here:

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Menopause Market?

North America was the largest region in the menopause market in 2025. The regions covered in the menopause market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Menopause Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13190&type=smp

Browse Through More Reports Similar to the Global Menopause Market 2026, By The Business Research Company

Menopause Global Market Report

https://www.thebusinessresearchcompany.com/report/menopause-global-market-report

Vasomotor Menopausal Symptoms Vms Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/vasomotor-menopausal-symptoms-vms-treatment-global-market-report

Hormone Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795